Ethics declarations Ethics approval and consent to participate All animal experiments were approved by the Animal Care and Use Committee of the Institute of Animal Management, Capital Medical University (permit no
This review summarizes our current understanding of how changes in intra-portal insulin delivery to the liver in health, disease states and drug therapy use and misuse that leads to alterations in GH/IGF-I secretion that may dictate management decisions in afflicted patients
Movements were monitored for 3.5 h, from 9:00 a.m
The gut microbiota exerts syntrophic, symbiotic, and mutualistic interactions in the mucus layer, thus creating the environment which drives microbial community selection and defines physical properties of the mucus layer
CAS 89030-95-5 (peptide), 49557-75-7 (complex)
FDA Drug Approval Database